ASML vs RARE · P/E 57, $665.37B cap vs rev $350.0M
ASML Holding NV ADR (ASML) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ASML and RARE stock pages for the full models.
Not investment advice.